<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:54:24Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/12893" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/12893</identifier><datestamp>2026-10-18T20:27:45Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>The Effect of Thiamine Pyrophosphate and Tocilizumab Alone and in Combination upon Ethanol-Induced Peripheral Neuropathy and Neuropathic Pain in Rats</dc:title><dc:creator>Ekinci, Bilge</dc:creator><dc:creator>Suleyman, Bahadir</dc:creator><dc:creator>Mammadov, Renad</dc:creator><dc:creator>Cankaya, Murat</dc:creator><dc:creator>Yazici, Gulce Naz</dc:creator><dc:creator>Suleyman, Zeynep</dc:creator><dc:creator>Dal, Cagatay Nusret</dc:creator><dc:creator>Ergul, Emine Esra</dc:creator><dc:creator>Onk, Didem</dc:creator><dc:creator>Suleyman, Halis</dc:creator><dc:subject>ethanol</dc:subject><dc:subject>neuropathic disease</dc:subject><dc:subject>peripheral neuropathy</dc:subject><dc:subject>rat</dc:subject><dc:subject>thiamine pyrophosphate</dc:subject><dc:subject>tocilizumab</dc:subject><dc:subject>alcohol</dc:subject><dc:subject>cocarboxylase</dc:subject><dc:subject>distilled water</dc:subject><dc:subject>glutathione</dc:subject><dc:subject>interleukin 1beta</dc:subject><dc:subject>interleukin 6</dc:subject><dc:subject>ketamine</dc:subject><dc:subject>malonaldehyde</dc:subject><dc:subject>tumor necrosis factor</dc:subject><dc:subject>anesthesia</dc:subject><dc:subject>animal experiment</dc:subject><dc:subject>animal model</dc:subject><dc:subject>animal tissue</dc:subject><dc:subject>Article</dc:subject><dc:subject>biochemistry</dc:subject><dc:subject>controlled study</dc:subject><dc:subject>cytokine production</dc:subject><dc:subject>drug megadose</dc:subject><dc:subject>histopathology</dc:subject><dc:subject>male</dc:subject><dc:subject>nervous tissue</dc:subject><dc:subject>neuropathic pain</dc:subject><dc:subject>nonhuman</dc:subject><dc:subject>pain threshold</dc:subject><dc:description>The aim of the study to determine the effects of thiamine pyrophosphate (TPP) and tocilizumab (TCZ) either alone or in combination on ethanol-induced neuropathic pain and peripheral neuropathy in rat nerve tissues, biochemically and histopathologically. Albino Wistar male rats were divided into five groups as the healthy (HG), ethanol alone (EtOH), TPP + ethanol (TPE), TCZ + ethanol (TCE), and TPP + TCZ + ethanol (TPTE) groups. TPE (n = 6), TCE (n = 6) and TPTE (n = 6) groups were injected with 20 mg/kg TPP, 8 mg/kg TCZ, and 20 mg/kg TPP+8 mg/kg TCZ intraperitoneally (respectively). Distilled water were given the HG (n = 6) and EtOH (n = 6) groups. One hour after the drugs and distilled water were administered, 35% ethanol was administered orally by lavage at a 5 g/kg dose to the TPE, TCE, TPTE, and EtOH groups. Paw pain thresholds of animals were measured using Basile Algesimeter. TPTE, which suppressed the decrease of the pain threshold with ethanol more significantly than TPP and TCZ. The best inhibitor of MDA increase and inhibit the reduction of tGSH by etanol was listed as TPTE &gt; TPE &gt; TCZ. The potency of suppressing the increase in cytokine production with ethanol was listed as TPTE &gt; TCE &gt; TPE. In conclusion, the results indicate that TPP+TCZ may be more beneficial than TPP and TCZ alone in treating ethanol-related neuro-pathic pain. © 2022, Colegio de Farmaceuticos de la Provincia de Buenos Aires. All rights reserved.</dc:description><dc:publisher>Colegio de Farmaceuticos de la Provincia de Buenos Aires</dc:publisher><dc:date>2022</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/12893</dc:identifier><dc:identifier>0326-2383</dc:identifier><dc:language>en</dc:language><dc:relation>Latin American Journal of Pharmacy</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/12893</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>